[go: up one dir, main page]

DK1638586T3 - Synergistisk sammensætning til behandling af diabetes mellitus - Google Patents

Synergistisk sammensætning til behandling af diabetes mellitus

Info

Publication number
DK1638586T3
DK1638586T3 DK04732676T DK04732676T DK1638586T3 DK 1638586 T3 DK1638586 T3 DK 1638586T3 DK 04732676 T DK04732676 T DK 04732676T DK 04732676 T DK04732676 T DK 04732676T DK 1638586 T3 DK1638586 T3 DK 1638586T3
Authority
DK
Denmark
Prior art keywords
treatment
diabetes mellitus
synergistic composition
concentration ranging
composition
Prior art date
Application number
DK04732676T
Other languages
English (en)
Inventor
Sunil Bhaskaran
Vishwaraman Mohan
Original Assignee
Indus Biotech Pvt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indus Biotech Pvt Ltd filed Critical Indus Biotech Pvt Ltd
Application granted granted Critical
Publication of DK1638586T3 publication Critical patent/DK1638586T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
DK04732676T 2003-05-14 2004-05-13 Synergistisk sammensætning til behandling af diabetes mellitus DK1638586T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47074203P 2003-05-14 2003-05-14
PCT/IB2004/001550 WO2004100968A2 (en) 2003-05-14 2004-05-13 A synergistic composition for the treatment of diabetes mellitus

Publications (1)

Publication Number Publication Date
DK1638586T3 true DK1638586T3 (da) 2008-06-23

Family

ID=33452413

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04732676T DK1638586T3 (da) 2003-05-14 2004-05-13 Synergistisk sammensætning til behandling af diabetes mellitus

Country Status (7)

Country Link
US (3) US7141254B2 (da)
EP (1) EP1638586B1 (da)
JP (1) JP4353982B2 (da)
AT (1) ATE390142T1 (da)
DE (1) DE602004012745T2 (da)
DK (1) DK1638586T3 (da)
WO (1) WO2004100968A2 (da)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7815946B1 (en) * 2001-04-05 2010-10-19 Diakron Pharmaceuticals, Inc. Anti-diabetic and cholesterol lowering preparation from fenugreek seeds
WO2004100968A2 (en) * 2003-05-14 2004-11-25 Indus Biotech Pvt. Ltd. A synergistic composition for the treatment of diabetes mellitus
WO2005049006A1 (ja) * 2003-11-21 2005-06-02 Ajinomoto Co., Inc. 糖尿病治療剤
CN101193852A (zh) * 2005-02-18 2008-06-04 因诺迪亚有限公司 4-羟基异亮氨酸类似物及其用途
JP2008538211A (ja) * 2005-03-22 2008-10-16 イノディア インク． 肥満及び関連する症候群の予防及び治療における使用のための化合物及び組成物
US20070077310A1 (en) * 2005-10-03 2007-04-05 University Of Tennessee Research Foundation Methods of reducing the production of reactive oxygen species and methods of screening or identifying compounds and compositions that reduce the production of reactive oxygen species
US20100048545A1 (en) * 2006-03-22 2010-02-25 Innodia Inc. Compounds and Compositions for Use in the Prevention and Treatment of Disorders of Fat Metabolism and Obesity
EP1859786A1 (en) * 2006-05-16 2007-11-28 Frutarom Netherlands B.V. A method to reduce the symptoms of heartburn and gastro-oesophageal reflux disease (GERD) by specific polysaccharides
US8865237B2 (en) * 2006-06-01 2014-10-21 Department Of Biotechnology Method of preparing dialysed extract of fenugreek seeds which induces hypoglycemia, mediated, in part, via stimulation of insulin signaling pathway
US20080075792A1 (en) * 2006-09-21 2008-03-27 Naturalendo Tech Co., Ltd. Method for inhibiting the activity of DPP-IV and lowering blood glucose level
US20080199517A1 (en) * 2007-02-19 2008-08-21 Indus Biotech Private Ltd Composition and a process thereof
JP5201767B2 (ja) * 2007-03-05 2013-06-05 インダス バイオテック プライベート リミテッド 医薬組成物およびその調製方法
US20080228056A1 (en) 2007-03-13 2008-09-18 Michael Blomquist Basal rate testing using frequent blood glucose input
US7751907B2 (en) 2007-05-24 2010-07-06 Smiths Medical Asd, Inc. Expert system for insulin pump therapy
US8221345B2 (en) 2007-05-30 2012-07-17 Smiths Medical Asd, Inc. Insulin pump based expert system
US20090177147A1 (en) 2008-01-07 2009-07-09 Michael Blomquist Insulin pump with insulin therapy coaching
US8986253B2 (en) 2008-01-25 2015-03-24 Tandem Diabetes Care, Inc. Two chamber pumps and related methods
KR101257331B1 (ko) * 2008-05-08 2013-04-23 인두스 바이오텍 프라이빗 리미티드 갈락토만난을 포함하는 조성물 및 그의 제조방법
US8288364B2 (en) * 2008-05-09 2012-10-16 Indus Biotech Private Limited Botanically derived composition and a process thereof
EP2323676B1 (en) * 2008-06-25 2015-07-15 Department of Biotchnology (DBT) Protein based product from fenugreek seeds that regulates dyslipidemia and obesity, and a process for the preparation thereof
NZ591713A (en) 2008-08-15 2013-07-26 Ironwood Pharmaceuticals Inc Solid stable formulations of linaclotide for oral administration
US8408421B2 (en) 2008-09-16 2013-04-02 Tandem Diabetes Care, Inc. Flow regulating stopcocks and related methods
CA2737461A1 (en) 2008-09-19 2010-03-25 Tandem Diabetes Care, Inc. Solute concentration measurement device and related methods
EP2349264A1 (en) * 2008-11-17 2011-08-03 Technische Universität München Pyrimidinium derivatives for use in the treatment or prevention of diabetes
CA2921304C (en) 2009-07-30 2018-06-05 Tandem Diabetes Care, Inc. Infusion pump system with disposable cartridge having pressure venting and pressure feedback
JP2013501071A (ja) * 2009-08-06 2013-01-10 アイロンウッド ファーマシューティカルズ， インコーポレイテッド リナクロチドを含む処方物
US8882701B2 (en) 2009-12-04 2014-11-11 Smiths Medical Asd, Inc. Advanced step therapy delivery for an ambulatory infusion pump and system
PL2536742T3 (pl) 2010-02-17 2017-11-30 Ironwood Pharmaceuticals, Inc. Leczenie zaburzeń żołądkowo-jelitowych
EP2556828B1 (en) 2010-04-07 2017-08-02 Otsuka Pharmaceutical Factory, Inc. Composition for amelioration of hypoalbuminemia
EP3626253B8 (en) 2010-08-11 2022-04-20 Ironwood Pharmaceuticals, Inc. Stable formulations of linaclotide
CN102697781B (zh) * 2011-06-21 2013-12-04 中国人民解放军第三军医大学第二附属医院 胡芦巴碱作为制备防治糖尿病及其并发症药物的应用
CN102225082B (zh) * 2011-06-22 2017-05-24 中国人民解放军第三军医大学第二附属医院 一种防治糖尿病及其并发症的药物和其制备方法
EP3466418A1 (en) 2011-07-15 2019-04-10 NuSirt Sciences, Inc. Compositions and methods for modulating metabolic pathways
DK2776055T3 (da) 2011-08-17 2017-03-06 Ironwood Pharmaceuticals Inc Behandlinger for gastrointestinale forstyrrelser
US9198454B2 (en) 2012-03-08 2015-12-01 Nusirt Sciences, Inc. Compositions, methods, and kits for regulating energy metabolism
US9180242B2 (en) 2012-05-17 2015-11-10 Tandem Diabetes Care, Inc. Methods and devices for multiple fluid transfer
US9555186B2 (en) 2012-06-05 2017-01-31 Tandem Diabetes Care, Inc. Infusion pump system with disposable cartridge having pressure venting and pressure feedback
US9238100B2 (en) 2012-06-07 2016-01-19 Tandem Diabetes Care, Inc. Device and method for training users of ambulatory medical devices
CN108452311A (zh) 2012-11-13 2018-08-28 纽斯尔特科学公司 用于增强能量代谢的组合物和方法
US10201656B2 (en) 2013-03-13 2019-02-12 Tandem Diabetes Care, Inc. Simplified insulin pump for type II diabetics
US10357606B2 (en) 2013-03-13 2019-07-23 Tandem Diabetes Care, Inc. System and method for integration of insulin pumps and continuous glucose monitoring
US9173998B2 (en) 2013-03-14 2015-11-03 Tandem Diabetes Care, Inc. System and method for detecting occlusions in an infusion pump
US9492608B2 (en) 2013-03-15 2016-11-15 Tandem Diabetes Care, Inc. Method and device utilizing insulin delivery protocols
WO2014152016A1 (en) 2013-03-15 2014-09-25 Nusirt Sciences, Inc. Leucine and nicotinic acid reduces lipid levels
US10016561B2 (en) 2013-03-15 2018-07-10 Tandem Diabetes Care, Inc. Clinical variable determination
EP2981259B1 (en) * 2013-04-02 2021-06-09 Indus Biotech Private Limited A composition for treating neuropathy, a process and a method of treatment thereof
MX2016011063A (es) 2014-02-27 2016-11-30 Nusirt Sciences Inc Composiciones y metodos para la reduccion o prevencion de esteatosis hepatica.
US9669160B2 (en) 2014-07-30 2017-06-06 Tandem Diabetes Care, Inc. Temporary suspension for closed-loop medicament therapy
US10391060B2 (en) 2015-08-06 2019-08-27 Rubicon Research Private Limited Particulate delivery systems
US10569016B2 (en) 2015-12-29 2020-02-25 Tandem Diabetes Care, Inc. System and method for switching between closed loop and open loop control of an ambulatory infusion pump
JP7072357B2 (ja) * 2016-08-24 2022-05-20 公益財団法人東洋食品研究所 糖取り込み組成物
EP3479845A1 (en) * 2017-11-06 2019-05-08 Stalicla S.A. Challenge test for diagnosing subtype of autism spectrum disease

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2695317B1 (fr) * 1992-09-07 1995-03-10 Monal Lab Composition apte à stimuler la sécrétion d'insuline destinée au traitement du diabète non insulino-dépendant.
IL108583A (en) * 1994-02-07 1997-06-10 Yissum Res Dev Co Galactomannan emulsions and comestible products containing the same
CA2206157C (en) * 1997-05-26 2000-06-13 Cheng, Peter Method of extraction of commercially valuable fractions of fenugreek
IN192689B (da) * 2000-02-14 2004-05-15 Rao Gariimella Bhaskar Dr
US6692777B2 (en) * 2001-01-22 2004-02-17 Seung Young Lee Pharmaceutical composition for the treatment of diabetes mellitus
WO2004100968A2 (en) * 2003-05-14 2004-11-25 Indus Biotech Pvt. Ltd. A synergistic composition for the treatment of diabetes mellitus

Also Published As

Publication number Publication date
US20050008716A1 (en) 2005-01-13
EP1638586A2 (en) 2006-03-29
ATE390142T1 (de) 2008-04-15
WO2004100968A3 (en) 2005-01-20
WO2004100968A2 (en) 2004-11-25
US7674485B2 (en) 2010-03-09
DE602004012745D1 (de) 2008-05-08
US7141254B2 (en) 2006-11-28
JP2006528235A (ja) 2006-12-14
US7641925B2 (en) 2010-01-05
US20060153937A1 (en) 2006-07-13
DE602004012745T2 (de) 2009-04-09
US20060134242A1 (en) 2006-06-22
JP4353982B2 (ja) 2009-10-28
EP1638586B1 (en) 2008-03-26

Similar Documents

Publication Publication Date Title
DK1638586T3 (da) Synergistisk sammensætning til behandling af diabetes mellitus
CY1123084T1 (el) Θεραπεια των ασθενειων αποθηκευσης γλυκογονου τυπου ιι
EA200501592A1 (ru) Способы и композиции для введения агонистов trpv1
DK1539166T3 (da) Farmaceutiske sammensætninger indeholdende dextromethorphan og quinidin til behandling af neurologiske sygdomme
ATE556711T1 (de) Verfahren zur verbesserung der hautqualität
WO2005027895A3 (en) Thyroid hormone analogs and methods of use in angiogenesis
WO2004091540A3 (en) Methods of treating pain and compositions for use therefor
SE0301886D0 (sv) New use V
EP1505990A4 (en) METHOD FOR THE TREATMENT OF HEPATITIS
DE60310400D1 (de) Botulinustoxine zur behandlung von priapismus
EA200400734A1 (ru) Способ и композиция для потенциирования действия опиатного анальгетика
NO20081149L (no) Fremgangsmate for behandling av B-celle-maligniteter ved bruk av TACI-IG fusjonsmolekyl
DK1207870T3 (da) Farmaceutiske præparater, der indeholder N-palmitoylethanolamid og anvendelse deraf
EA200700407A1 (ru) Производные хиназолина и их использования при лечении тромбоцитемии
HRP20080617T3 (hr) Liječenje i dijagnosticiranje novotvorina pomoću limfopoetina iz strome timusa
DE602006020562D1 (de) Hren dafür
DE60236927D1 (de) Suchtpraevention in der schmerzbehandlung mit gamma vinyl gaba
EA200500175A1 (ru) Соль морфин-6-глюкуронида
SE0301947D0 (sv) New method and uses
WO2004030623A3 (en) Nitroxide radioprotector formulations and methods of use
DE60313344D1 (de) Verwendung von 4-pyridylmethyl-phthalazin-derivaten zur herstellung eines medikaments zur behandlung von myelodysplastischen syndromen
DE602004021395D1 (de) Verfahren zur behandlung von hepatozellulärem karzinom
SE9602145D0 (sv) New improved formulation for treatment of thromboembolism
ATE502639T1 (de) 4-hydroxypiperidin-derivate zur verwendung als antimycobakterielle mittel
RU2004123072A (ru) Способ лечения больных остеоартрозом